At a glance
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) is a federal competitive grant from National Institutes of Health for the science & technology sector. Funding is up to $25K. Eligible applicants: Native American tribal governments (Federally recognized); State governments; Private institutions of higher education; Special district governments; Others (see text field entitled "Additional Information on Eligibility. The application deadline is January 7, 2028. Apply via the official listing at www.grants.gov.
- Amount
- Up to $25K
- Deadline
- Jan 7, 2028
- Type
- Competitive
- Status
- Open
About this program
NIMH seeks applications for research projects to evaluate the effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health conditions affecting youth, adults, and older adults. This Notice of Funding Opportunity (NOFO) encourages clinical trials to establish the effectiveness and test hypotheses regarding moderators, mediators, and mechanisms of action of post-acute phase therapeutic and services interventions that are matched to the stage of illness in terms of both their focus (e.g., consolidating and maintaining gains from initial treatment, managing residual symptoms/impairment, preventing relapse, promoting adherence and appropriate service use) and intensity/burden for promoting optimal longer-term outcomes. This NOFO is intended to support effectiveness trials testing post-acute phase interventions that are statistically powered to provide a definitive answer regarding the study intervention's effectiveness. Support for pilot effectiveness trials to evaluate the initial feasibility, tolerability, acceptability, safety and preliminary indications of effectiveness of post-acute phase intervention approaches is provided via a companion R34 (Currently TEMP-24814)
Who can apply
Native American tribal governments (Federally recognized); State governments; Private institutions of higher education; Special district governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Native American tribal organizations (other than Federally recognized tribal governments); Independent school districts; Public and State controlled institutions of higher education; For profit organizations other than small businesses; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; County governments; Public housing authorities/Indian housing authorities; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education. Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
How to apply
Apply through Grants.gov using funding opportunity number PAR-25-207. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) NIH · See listing · Jan 6, 2028 Open
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) NIH · See listing · Jan 7, 2028 Open
- Cannabis Research and Innovation Funding Opportunity (RIFO) Department of Fish and Wildlife · Dependant on number of submissions received, application process, etc. · Rolling Open
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) NIH · See listing · Sep 7, 2027 Open